Two studies reported numerically fewer new infections in de-escalated patients (defined as a relative group difference ≥25%); however, this difference did not reach statistical significance.
← all excerpts
De-Escalation of Anti-Tumor Necrosis Factor Alpha Agents and Reduction in Adverse Effects: A Systematic Review.
1
—
—